Only an asteroid on a collision course with Earth, or an ISIS nuclear detonation, could make the world seem any more interesting than it already is. Under the …
Isis Pharmaceuticals announced Friday that it is finally changing its name to something that people won't confuse with the terrorist group that took credit for the recent Paris attacks and other deadly episodes of violence. In explaining its …
sold $422,369 worth of stock or 15,500 shares. 30,000 shares were sold by Dawkins ... and may have played a role in connecting the Catalan cell with ISIS. Josep …
Isis Pharmaceuticals is a largely development-stage biotech with many promising business attributes. The stock has had large moves the past few years. Recently ISIS has plunged even as substantive news flow keeps appearing that …
Matthew M. Reed is Vice President of Foreign Reports, Inc., a Washington, DC-based consulting firm focused on oil and politics in the Middle East. Connecting the dots when it comes to ISIS oil is no easy task. As Part 1 made clear, we’re …
While Iraq has declared victory in Mosul and the battle for Raqqa heats up, the U.S. held a three-day summit of the Global Coalition to Defeat ISIS that ended Thursday, celebrating some key milestones and taking stock of the long road …
"Chemtrail Kelli's got her head in the clouds with insane ideas", a narrator …
With biotech stocks continuing to push higher again this year, the Street is buzzing with the possibility that a bubble is forming within the industry. And with top companies like Isis Pharmaceuticals (NASDAQ:IONS)trading at over 40 times …
Diageo plc (NYSE:DEO) Stock Traded Well Above Its 50 Day Average Societe Generale ... the attacks were plotting much deadlier carnage using explosives …
What: Shares of the antisense drugmaker Isis Pharmaceuticals (NASDAQ ... George Budwell has been writing about healthcare and biotechnology companies at the Motley Fool since 2013. His primary interests are novel small …